Encephalitis - 96 Studies Found
| Completed |
: A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis :
: 2005-11-29 : Drug: Rituximab 375 mg/m2 given as an IV infusion once weekly for four doses |
| Completed |
: Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients : Tick Borne Encephalitis : 2013-11-06 : Biological: TBE virus vaccine TBE virus vaccine FSME Immun is used in both arms for the study population |
| Completed |
: TBE Seropersistence up to 10 Years After First Booster in Adults : Tick-borne Encephalitis (TBE) : 2012-04-20 : Biological: FSME-IMMUN 0.5 ml Solution/suspension for injection (intramuscular injection into the deltoi |
| Completed |
: Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years : Tick-borne Encephalitis : 2005-09-08 : Biological: FSME-IMMUN NEW 0.25 ml |
| Completed |
: Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years. : Tick-borne Encephalitis : 2005-09-08 : Biological: Tick-borne encephalitis vaccine |
| Completed |
: Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years : Tick-borne Encephalitis : 2005-09-08 : Biological: FSME-IMMUN 0.5ml |
| Completed |
: Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years. : Tick-borne Encephalitis : 2005-09-08 : Biological: Tick-borne Encephalitis Vaccine |
| Completed |
: Influence of Persistent CMV-infection on Immune Senescence : Immune Senescence : 2007-04-17 : Biological: Vaccination against TBEV (FSME Immun CC) Intramuscular injection into the left (or right) de |
| Completed |
: Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults : West Nile Fever Encephalitis : 2004-10-21 :
|
| Completed |
: Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age : West Nile Virus : 2014-07-08 :
|